Indiana is now one of the top five states in the U.S. for number of life sciences employees (BIO/Battelle Technology Practice, 2013). The state’s life sciences industry boasts statistics that rival coastal hubs of activity and has gained national recognition for leadership in the life sciences. BioCrossroads seized an opportunity to do more with the state’s life sciences corporate and academic assets and bolsters tremendous growth to the sector by building unique collaborations, marketing its strengths, igniting a capital market, moving research from laboratory to the patient, and developing a one-of-a-kind institute to accelerate research and commercialization. The result is a vibrant and uniquely collaborative life sciences state-wide community that has increased its economic impact to the state by $31 billion in 13 years ($32B in 2002 and $63B in 2015).
Brenda Bratton joined BioCrossroads in January 2005 as Executive Assistant for David Johnson, President and CEO. Previously she worked at the law firm of Baker & Daniels for 15 years.
Brian, project director for BioCrossroads, has a strong background in life sciences market development and research, and is responsible for identifying and developing opportunities for growth within Indiana’s life sciences sector. He authors reports and performs market research on the industry and supports the City of Indianapolis’ and State’s economic development by providing market information to attract and grow life sciences companies.
Brian led the formation of the Central Indiana Corporate Partnership’s AgriNovus Indiana, a nonprofit established in 2013 to leverage Indiana’s strengths in agricultural innovation, working with industry CEOs, Indiana’s Lieutenant Governor and Purdue University to launch the new entity, publish a first-of-its-kind report and support early-stage ag-tech companies.
In addition, he serves as an advisor to Indiana Seed Fund II. He currently serves on the boards of Aarden Pharmaceuticals and Algaeon.
Prior to joining BioCrossroads, Brian was employed by Eli Lilly and Company in Corporate Affairs, where he ran the company’s political action committee. He also worked as a Senior Analyst in the company’s biotechnology unit and was a member of the team that established Lilly Systems Biology, Ltd. in Singapore. Previously, Brian was a manager in Arthur Andersen’s Assurance practice, providing audit and tax consulting to companies in the energy, software and healthcare industries.
Chris serves as project director for BioCrossroads. In this capacity, Chris focuses on promoting the entrepreneurial and institutional opportunities throughout Indiana’s life science community. He manages the BioCrossroads New Venture Competition and supports the Indiana Biosciences Research Institute, the 16 Tech Innovation District and OrthoWorx. Chris also serves as an advisor to the Indiana Seed Fund II and assists the fund manager in deal sourcing, diligence and execution of portfolio investments. He currently serves on the board of the Datalys Center for Sports Injury Research and Prevention.
Prior to joining BioCrossroads, Chris spent several years as the Director of Life Sciences for the Indiana Economic Development Corporation, where he led the state’s initiative to expand, attract, and retain life sciences corporations. He served on the board of directors for Indiana Health Information Technology, Inc. and the Indiana Cord Blood Bank. Previously, he also oversaw Indiana’s Health and Human Service agencies while at the Office of Management and Budget.
Chris earned a BS in Biology from Yale University, where he was a two-time Academic All-American, and an MBA from the Krannert School of Management at Purdue University
David L. Johnson
David L. Johnson
David L. Johnson was elected President and CEO of the Central Indiana Corporate Partnership (CICP) in December 2012. CICP is a unique strategic collaboration of business leaders and university presidents organized to develop initiatives, investments and projects that advance regional prosperity. Since 2005, Johnson has also served as President and CEO of CICP’s BioCrossroads life sciences initiative.
Johnson has been engaged with CICP for more than a decade as one of the founders of BioCrossroads, a market-based enterprise focused on strategic collaborations and investments for growing Indiana’s substantial life sciences sector. Among its many activities, BioCrossroads informs and educates; raises and invests venture capital funds in promising new companies; and builds collaborations of key partners from academia and industry. Through his work at BioCrossroads, Johnson has been responsible for raising over $350 million dollars in philanthropic, corporate and venture capital funding.
Johnson is an honors graduate of Harvard University, Harvard Law School and Oxford University, where he studied as a Rhodes Scholar.
Julie serves as the office manager for BioCrossroads, a role she has held since 2003. Prior to joining the organization, Julie worked at the Indy Partnership, the City of Indianapolis Mayor’s Office and the Indianapolis Zoo.
In addition, Julie serves as the membership manager and executive assistant to the COO for the Central Indiana Corporate Partnership. In her position as membership manager, Julie serves as the liaison to the members of CICP and handles the coordination of meetings and events for the members.
She is a graduate of Trine University in Angola, Ind.
Lori LeRoy is the Vice President of Communications for BioCrossroads and also serves in the same role at the Central Indiana Corporate Partnership, an organization that includes the chief executives of Central Indiana’s prominent corporations and university presidents in a strategic and collaborative effort dedicated to the region’s continued prosperity and growth. BioCrossroads is CICP’s sector initiative for the life sciences. She leads all public relations, marketing, advertising, and event development for both organizations.
LeRoy was previously marketing manager, communications for Roche Diagnostics Diabetes Care business area. She was also a public relations consultant at Roche where she managed product public relations for its laboratory, hospital, physician’s office and research products. With a strong background in consumer PR, brand awareness campaigns and health care/technology PR, she has also held positions as senior manager, corporate communications at Philips Consumer Electronics and corporate communications manager at AirTran Airways.
She earned a B.A. in English and Asian Studies from Oglethorpe University in Atlanta, where she also served as a member of the Alumni Association Board of Directors.
Nora Doherty joined BioCrossroads in 2003 after working many years with entrepreneurial companies. She is vice president of finance for BioCrossroads and managing director for its Seed Funds. In this role, she serves on the Board of Directors of portfolio companies including FAST, SonarMed, and Grest among others. Doherty also supports other program-related activities.
Doherty has a history of working for entrepreneurial companies. She was vice president of Electronic Evolutions and a co-founder, vice president of Operations and vice president Legal, Human Resources and Administration, and corporate secretary with Escient Technologies. Escient Technologies managed numerous consumer electronic and internet related businesses, including Gracenote® which was purchased by Sony in 2008.
Doherty received her BA and MBA from Indiana University, where she was a member of the honors program. She also received the “Excellence in Leadership” award as special recognition from the professors and administration of Indiana University MBA-CIP for leadership and contribution to the program.